GR3029324T3 - Improved immunotherapeutic method of preventing or treating viral respiratory tract disease - Google Patents

Improved immunotherapeutic method of preventing or treating viral respiratory tract disease

Info

Publication number
GR3029324T3
GR3029324T3 GR990400410T GR990400410T GR3029324T3 GR 3029324 T3 GR3029324 T3 GR 3029324T3 GR 990400410 T GR990400410 T GR 990400410T GR 990400410 T GR990400410 T GR 990400410T GR 3029324 T3 GR3029324 T3 GR 3029324T3
Authority
GR
Greece
Prior art keywords
respiratory tract
preventing
tract disease
treating viral
viral respiratory
Prior art date
Application number
GR990400410T
Other languages
English (en)
Inventor
Robert Merritt Chanock
Gregory Antone Prince
Kathleen Louise Coelingh
Brian Robert Murphy
Val Hemming
Judy Allyson Beeler
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of GR3029324T3 publication Critical patent/GR3029324T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR990400410T 1990-07-19 1999-02-10 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease GR3029324T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55509190A 1990-07-19 1990-07-19
PCT/US1991/005002 WO1992001473A1 (en) 1990-07-19 1991-07-19 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease

Publications (1)

Publication Number Publication Date
GR3029324T3 true GR3029324T3 (en) 1999-05-28

Family

ID=24215926

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400410T GR3029324T3 (en) 1990-07-19 1999-02-10 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease

Country Status (10)

Country Link
EP (1) EP0539522B1 (el)
JP (1) JP2631767B2 (el)
AT (1) ATE175123T1 (el)
AU (1) AU644210B2 (el)
CA (1) CA2087100A1 (el)
DE (1) DE69130708T2 (el)
DK (1) DK0539522T3 (el)
ES (1) ES2129028T3 (el)
GR (1) GR3029324T3 (el)
WO (1) WO1992001473A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016074A1 (en) * 1990-04-19 1991-10-31 Medimmune, Inc. Administration of monoclonal antibodies against respiratory viruses
GB9207479D0 (en) * 1992-04-06 1992-05-20 Scotgen Ltd Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
EP0671927B1 (en) * 1992-09-16 2003-01-15 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus
US6685942B1 (en) 1993-12-10 2004-02-03 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus
NZ269735A (en) * 1993-07-30 1998-01-26 Oravax Inc Monoclonal iga antibody against respiratory syncytial virus (rsv)
US5922344A (en) * 1995-02-10 1999-07-13 Abbott Laboratories Product for prevention of respiratory virus infection and method of use
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
SI1458360T1 (sl) 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
US20050271660A1 (en) * 2002-09-06 2005-12-08 Alexion Pharmaceuticals, Inc. Nebulization of monoclonal antibodies for treating pulmonary diseases
CA2638833A1 (en) * 2006-03-06 2007-09-13 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
MX2009009226A (es) 2007-03-06 2009-10-28 Symphogen As Anticuerpos recombinantes para el tratamiento de infecciones con el virus respiratorio sincitial.
EP3666285A3 (en) * 2012-10-29 2020-06-24 The University of North Carolina at Chapel Hill Compositions and methods for inhibiting pathogen infection
US10829543B2 (en) 2012-10-29 2020-11-10 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
MX2016012022A (es) 2014-04-03 2017-04-13 Csl Behring Ag Nebulizacion de inmunoglobulina.
US20210002355A1 (en) * 2018-03-21 2021-01-07 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2590674B1 (fr) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med Nouveaux reactifs de diagnostic
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
WO1991016074A1 (en) * 1990-04-19 1991-10-31 Medimmune, Inc. Administration of monoclonal antibodies against respiratory viruses
GB9019812D0 (en) * 1990-09-11 1990-10-24 Scotgen Ltd Novel antibodies for treatment and prevention of infection in animals and man

Also Published As

Publication number Publication date
CA2087100A1 (en) 1992-01-20
EP0539522A4 (en) 1993-09-08
AU644210B2 (en) 1993-12-02
EP0539522A1 (en) 1993-05-05
DE69130708T2 (de) 1999-05-27
DK0539522T3 (da) 1999-08-30
JPH06501928A (ja) 1994-03-03
JP2631767B2 (ja) 1997-07-16
ES2129028T3 (es) 1999-06-01
EP0539522B1 (en) 1998-12-30
DE69130708D1 (de) 1999-02-11
ATE175123T1 (de) 1999-01-15
AU8403091A (en) 1992-02-18
WO1992001473A1 (en) 1992-02-06

Similar Documents

Publication Publication Date Title
GR3029324T3 (en) Improved immunotherapeutic method of preventing or treating viral respiratory tract disease
GEP20012429B (en) Urease-Based Vaccine Against Helicobacter Infection
RU93058676A (ru) Оральное лечение геликобактерной инфекции
AU692100B2 (en) Reconstituted human antibody against human interleukin 6 receptor
CA2118010A1 (en) Antibodies specific for carcinoma-associated antigens
AU1471797A (en) Hybrid protein between CS from plasmodium and HBsAG
AU2936395A (en) Reconstituted human antibody against human interleukin-8
DE3268361D1 (en) New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process
EP0306524A4 (en) ANTI-DETERMINANTS DETECTED BY ANTIBODIES PRODUCED BY USING A RESTRICTED NUMBER OF ANTIGENT PRESENTING PATHOGENIC AGENTS OR DERIVATIVES.
EP0584715A3 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper.
AU8185494A (en) Diagnostic assay for alzheimer's disease
GR3014900T3 (en) Affinity associated vaccine.
NZ331557A (en) Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
EP0530216A4 (en) Administration of monoclonal antibodies against respiratory viruses
ATE285791T1 (de) Impfstoff, der acemannan als adjuvans enthält
EP0319333A3 (en) Method for the prevention of graft versus host disease
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
ZA965734B (en) Helicobacter vaccine antigen recognized by a protective monoclonal antibody (IgG 50).
DE69615537D1 (en) Helicobacter pylori antigen
GR970300022T1 (en) Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus
EP0334076A3 (en) Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
CS627787A1 (en) Mouse lymphocytar hybridome producing antibodies against antigen of b-hepatitis virus (hbeag)
FR2550203B1 (fr) Peptides synthetiques immunogenes porteurs d'un epitope caracteristique de l'antigene de surface du virus de l'hepatite b et compositions les contenant
EP0370768A3 (en) Monoclonal antibody for the antigen specific to carcinoma of the thyroid